Further clinical trials and extended studies are warranted to fully elucidate the safety, efficacy, and potential broader applications (eg. cancer, neuroinflammation) of these promising NLRP3 inhibitors, laying the foundation for their translation into novel therapeutic interventions. Here, NLRP3 is linked to cancer.